ARCT Q2 2019 Earnings — Arcturus Therapeutics Holdings Inc. Revenue & Financial Results | Market Cap Arena

ARCTArcturus Therapeutics Holdings Inc.

$210M

Q2 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$10M+325.5% YoY

Gross Profit

$3M28.4% margin

Operating Income

-$572,000-5.6% margin

Net Income

-$685,000-6.7% margin

EPS (Diluted)

$-0.07

QoQ Revenue Growth

+133.4%

Cash Flow

Operating Cash Flow

$9M

Free Cash Flow

$9M

Stock-Based Comp.

$403,000

Balance Sheet

Total Assets

$71M

Total Liabilities

$49M

Stockholders' Equity

$22M

Cash & Equivalents

$56M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$10M	$2M	+325.5%
Gross Profit	$3M	-$2M	+256.8%
Operating Income	-$572,000	-$10M	+94.3%
Net Income	-$685,000	-$10M	+93.1%

Revenue Segments

Other Collaboration Revenue

$4M100%